Prognostic significance of TNFRSF4 expression and development of a pathomics model to predict expression in hepatocellular carcinoma
- Zhaoyong Yan 1, Xiang Li 2, Zeyu Li 3, Sinan Liu 4, Hulin Chang 5
- Zhaoyong Yan 1, Xiang Li 2, Zeyu Li 3
- 1Department of Interventional Radiology, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.
- 2Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, 430000, China.
- 3Department of General Surgery, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.
- 4Department of SICU, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
- 5Department of Hepatobiliary Surgery, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.
- 0Department of Interventional Radiology, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) expression and a new pathomics model show promise as prognostic markers for hepatocellular carcinoma (HCC) survival. Gender impacts how these markers relate to patient outcomes.
Area Of Science
- Oncology
- Molecular Biology
- Pathology
Background
- Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) is implicated in cancer progression, particularly in hepatocellular carcinoma (HCC).
- Understanding TNFRSF4's prognostic value in HCC is crucial for improving patient outcomes.
Purpose Of The Study
- To investigate the prognostic significance of TNFRSF4 expression in HCC patients.
- To develop and validate a predictive pathomics model for TNFRSF4 expression in HCC.
Main Methods
- RNA-sequencing analysis of HCC patient cohort from TCGA database to assess TNFRSF4 expression and overall survival (OS).
- Hematoxylin-eosin staining and analysis to construct a pathomics model for predicting TNFRSF4 expression.
- Pathway enrichment, immune checkpoint marker, and immune cell infiltration analyses to elucidate biological mechanisms.
Main Results
- TNFRSF4 expression was elevated in HCC tumor tissues and correlated with advanced pathologic stage and residual tumor status.
- Higher TNFRSF4 expression was linked to unfavorable OS, especially in male HCC patients.
- The pathomics model accurately predicted TNFRSF4 expression and associated high scores with worse OS and increased mortality risk in males, implicating pathways like EMT and Tregs.
Conclusions
- TNFRSF4 expression and pathomics scores serve as potential prognostic biomarkers for HCC OS.
- Gender is a significant factor influencing the prognostic association of TNFRSF4 and pathomics scores in HCC.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:26
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
03:03
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

